Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients.
J Allergy Clin Immunol Pract
; 5(6): 1743-1745, 2017.
Article
in En
| MEDLINE
| ID: mdl-28988786
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urticaria
/
Anti-Allergic Agents
/
Omalizumab
/
Immunotherapy
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Allergy Clin Immunol Pract
Year:
2017
Document type:
Article
Country of publication:
United States